Pharma & Healthcare
Fierce competition, new customer needs, legal reforms the framework in the healthcare market is constantly changing.
Our Pharma & Healthcare CC supports all players in seizing opportunities and mastering their challenges.
Innovation in a dynamic market
The changes in healthcare are characterized by four tendencies:
- Market growth and new customer needs
Traditional healthcare is growing by 2-3% annually in the Western world. The privately funded "secondary healthcare market" is growing much faster. This is due to increasing healthcare needs that cannot be satisfied by existing offers. - Constantly changing framework
Demographic developments and cost increases mean healthcare is subject to constant reforms. The market players must be able to quickly adjust to new circumstances. - Converging submarkets and changing roles of market players
The healthcare market is becoming more and more integrated. The boundaries between statutory and private health insurance are becoming blurred; payors and providers are coming together in integrated healthcare provision and e-health; and the industry and health insurance companies are developing joint business models. - The pace of innovation
Traditional healthcare products such as pharma, medical devices and biotechnology are converging in many areas, thereby offering completely new treatment options.
The privately funded healthcare market is constantly coming up with new ideas and products: MP3 players are suddenly communicating with sneakers (cooperation of Apple with Nike), supermarkets are offering medical treatment (WalMart in the US), women's magazines are developing joint product lines with frozen food manufacturers.
Numerous and diverse projects mean we know all player types and take an integrated approach to viewing the healthcare market. Where appropriate, we bring the players together to collaborate and give them a competitive edge.
Our state-of-the-art projects in strategic realignment, profit boosting/cost cutting, marketing/sales, organization or M&A help make the healthcare market more innovative.
|
Fight or flight? - Diverzifikace vs. Léky na předpis - Úkol pro udržitelný růst
Spolu s postupnou obnovou automobilové produkce se výnosy dodavatelů pro automobilový průmysl dostávají téměř na stejnou úroveň jako v době před krizí … >> |
|
Co bude dál? Inovace v pojetí inovací ve farmaceutickém průmyslu
Po extrémně dlouhou dobu byly inovace ve farmaceutickém průmyslu orientovány na produkt. Všichni věděli co tím produktem je a jak vypadá – tableta … >> |


